MRI based on iron oxide nanoparticles contrast agents: effect of oxidation state and architecture
Source abstract
Abstract
Iron oxide nanoparticles (IONPs) extensively employed beyond regenerative medicines to imaging disciplines because of their great constituents for magneto-responsive nano-systems. The unique superparamagnetic behavior makes IONPs very suitable for hyperthermia and imaging applications. From the last decade, versatile functionalization with surface capabilities, efficient contrast properties and biocompatibilities make IONPs an essential imaging contrast agent for magnetic resonance imaging (MRI). IONPs have shown signals for both longitudinal relaxation and transverse relaxation; therefore, negative contrast as well as dual contrast can be used for imaging in MRI. In the current review, we have focused on different oxidation state of iron oxides, i.e., magnetite, maghemite and hematite for their T1 and T2 contrast enhancement properties. We have also discussed different factors (synthesis protocols, biocompatibility, toxicity, architecture, etc.) that can affect the contrast properties of the IONPs.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Iron oxide chemistry and applications · Characterization and Applications of Magnetic Nanoparticles
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Aggarwal P, Hall JB et al (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61(6):428–43710.1016/j.addr.2009.03.009 ↗
2. Albornoz C, Sileo EE et al (2004) Magnetic polymers of maghemite (γ-Fe2O3) and polyvinyl alcohol. Phys B Condens Matter 354(1):149–15310.1016/j.physb.2004.09.038 ↗
3. Alexiou C, Jurgons R et al (2006) Medical applications of magnetic nanoparticles. J Nanosci Nanotechnol 6(9-10):2762–276810.1166/jnn.2006.464 ↗
4. Arshad M, Siddiqui HA et al (2016) Synthesis of iron oxide magnetic nanoparticle by sol-gel method and their characterization. Professor Dr. Muhammad Tufail Convener 98:98
5. Azhdarzadeh M, Atyabi F et al (2016) Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer. Colloids Surf B Biointerfaces 143:224–23210.1016/j.colsurfb.2016.02.058 ↗
6. Ba-Abbad MM, Takriff MS et al (2017) Size and shape controlled of α-Fe2O3 nanoparticles prepared via sol–gel technique and their photocatalytic activity. J Sol-Gel Sci Technol 81(3):880–89310.1007/s10971-016-4228-4 ↗
7. Baaziz W, Pichon BP et al (2014) Magnetic iron oxide nanoparticles: reproducible tuning of the size and nanosized-dependent composition, defects, and spin canting. J Phys Chem C 118(7):3795–381010.1021/jp411481p ↗
8. Bae KH, Kim YB et al (2010) Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast T 1-and T 2-weighted magnetic resonance imaging. Bioconjug Chem 21(3):505–51210.1021/bc900424u ↗
9. Bagwe R, Kanicky J et al (2001) Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit Rev Ther Drug Carrier Syst 18(1):77
10. Basak S, Chen D-R et al (2007) Electrospray of ionic precursor solutions to synthesize iron oxide nanoparticles: modified scaling law. Chem Eng Sci 62(4):1263–126810.1016/j.ces.2006.11.029 ↗
11. Bashir M, Riaz S et al (2014) Magnetic Properties of Fe 3 O 4 Stabilized Zirconia. IEEE Trans Magn 50(8):1–410.1109/TMAG.2014.2312207 ↗
12. Basti H, Tahar LB et al (2010) Catechol derivatives-coated Fe 3 O 4 and γ-Fe 2 O 3 nanoparticles as potential MRI contrast agents. J Colloid Interface Sci 341(2):248–25410.1016/j.jcis.2009.09.043 ↗
13. Beg MS, Mohapatra J et al (2017) Porous Fe 3 O 4-SiO 2 core-shell nanorods as high-performance MRI contrast agent and drug delivery vehicle. J Magn Magn Mater 428:340–34710.1016/j.jmmm.2016.12.079 ↗
14. Bermudez E, Mangum JB et al (2004) Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77(2):347–35710.1093/toxsci/kfh019 ↗
15. Bhavani P, Rajababu C et al (2016) Synthesis and characterization of iron oxide nanoparticles prepared hydrothermally at different reaction temperatures and pH. Int J Mater Res 107(10):942–94710.3139/146.111417 ↗
16. Bhosale RR, Kumar A et al (2016) Propylene oxide assisted sol–gel synthesis of zinc ferrite nanoparticles for solar fuel production. Ceram Int 42(2):2431–243810.1016/j.ceramint.2015.10.043 ↗
17. Bhosale RR, Shende RV et al (2012) Sol-gel derived NiFe 2 O 4 modified with ZrO 2 for hydrogen generation from solar thermochemical water-splitting reaction. MRS Online Proceedings Library Archive:1387
18. Blanco-Andujar C, Walter A et al (2016) Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia. Nanomedicine 11(14):1889–191010.2217/nnm-2016-5001 ↗
19. Bomati-Miguel O, Miguel-Sancho N et al (2014) Ex vivo assessment of polyol coated-iron oxide nanoparticles for MRI diagnosis applications: toxicological and MRI contrast enhancement effects. J Nanopart Res 16(3):1–1310.1007/s11051-014-2292-7 ↗
20. Bomatí-Miguel O, Morales MP et al (2005) Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging. Biomaterials 26(28):5695–570310.1016/j.biomaterials.2005.02.020 ↗
21. Bondarenko O, Juganson K et al (2013) Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: a critical review. Arch Toxicol 87(7):1181–120010.1007/s00204-013-1079-4 ↗
22. Brahma P, Banerjee S et al (2002) Properties of nanocomposites of α-Fe and Fe 3 O 4. J Magn Magn Mater 246(1):162–16810.1016/S0304-8853(02)00044-6 ↗
23. Brooks RA, Moiny F et al (2001) On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med 45(6):1014–102010.1002/mrm.1135 ↗
24. Brunner TJ, Wick P et al (2006) vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40(14):4374–438110.1021/es052069i ↗
25. Bucci OM, Crocco L et al (2015) On the optimal measurement configuration for magnetic nanoparticles-enhanced breast cancer microwave imaging. IEEE Trans Biomed Eng 62(2):407–41410.1109/TBME.2014.2355411 ↗
26. Budde MD, Frank JA (2009) Magnetic tagging of therapeutic cells for MRI. J Nucl Med 50(2):171–17410.2967/jnumed.108.053546 ↗
27. Bulte JW, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17(7):484–49910.1002/nbm.924 ↗
28. Cedervall T, Lynch I et al (2007) Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci 104(7):2050–205510.1073/pnas.0608582104 ↗
29. Chamundeeswari M, Sastry T et al (2013) Iron nanoparticles from animal blood for cellular imaging and targeted delivery for cancer treatment. Biochim Biophys Acta Gen Subj 1830(4):3005–301010.1016/j.bbagen.2012.12.031 ↗
30. Chatterjee S, Sarkar K (2013) A computational and mathematical approach towards the design and synthesis of uniform Au seed decorated Fe 3 O 4 nanoparticle for potential bio-application. Procedia Technol 10:457–46310.1016/j.protcy.2013.12.383 ↗
31. Chen D-H, He X-R (2001) Synthesis of nickel ferrite nanoparticles by sol-gel method. Mater Res Bull 36(7):1369–137710.1016/S0025-5408(01)00620-1 ↗
32. Chen F, Gerion D (2004) Fluorescent CdSe/ZnS nanocrystal–peptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Lett 4(10):1827–183210.1021/nl049170q ↗
33. Chen G, Chen W et al (2009) MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. Biomaterials 30(10):1962–197010.1016/j.biomaterials.2008.12.043 ↗
34. Chen H, Sulejmanovic D et al (2014) Iron-loaded magnetic nanocapsules for pH-triggered drug release and MRI imaging. Chem Mater 26(6):2105–211210.1021/cm404168a ↗
35. Chen R, Ling D et al (2015) Parallel comparative studies on mouse toxicity of oxide nanoparticle-and gadolinium-based T1 MRI contrast agents. ACS Nano 9(12):12425–1243510.1021/acsnano.5b05783 ↗
36. Chen X, Gambhir SS et al (2011) Theranostic nanomedicine. Acc Chem Res 44(10):841–84110.1021/ar200231d ↗
37. Cheng C, Xu F et al (2011) Facile synthesis and morphology evolution of magnetic iron oxide nanoparticles in different polyol processes. New J Chem 35(5):1072–107910.1039/c0nj00986e ↗
38. Cheong S, Ferguson P et al (2011) Simple synthesis and functionalization of iron nanoparticles for magnetic resonance imaging. Angew Chem Int Ed 50(18):4206–420910.1002/anie.201100562 ↗
39. Chin AB, Yaacob II (2007) Synthesis and characterization of magnetic iron oxide nanoparticles via w/o microemulsion and Massart's procedure. J Mater Process Technol 191(1):235–23710.1016/j.jmatprotec.2007.03.011 ↗
40. Clapsaddle BJ, Gash AE et al (2003) Silicon oxide in an iron (III) oxide matrix: the sol–gel synthesis and characterization of Fe–Si mixed oxide nanocomposites that contain iron oxide as the major phase. J Non-Cryst Solids 331(1):190–20110.1016/j.jnoncrysol.2003.08.068 ↗
41. Clarkson R (2002) Blood-pool MRI contrast agents: properties and characterization. Springer, Contrast Agents I, pp 201–235
42. Colvin, V. (2003). The potential environmental impact of engineered nanomaterials. Nat Biotechnol 21:1166–1170. Find this article online.10.1038/nbt875 ↗
43. Couture P, Williams G et al (2017) Nanocrystalline multiferroic BiFeO 3 thin films made by room temperature sputtering and thermal annealing, and formation of an iron oxide-induced exchange bias. J Alloys Compd 695:3061–306810.1016/j.jallcom.2016.11.344 ↗
44. Cui H, Liu Y et al (2013) Structure switch between α-Fe 2 O 3, γ-Fe 2 O 3 and Fe 3 O 4 during the large scale and low temperature sol–gel synthesis of nearly monodispersed iron oxide nanoparticles. Adv Powder Technol 24(1):93–9710.1016/j.apt.2012.03.001 ↗
45. Cui X, Belo S et al (2014) Aluminium hydroxide stabilised MnFe 2 O 4 and Fe 3 O 4 nanoparticles as dual-modality contrasts agent for MRI and PET imaging. Biomaterials 35(22):5840–584610.1016/j.biomaterials.2014.04.004 ↗
46. Dalle-Donne I, Rossi R et al (2007) S-glutathionylation in protein redox regulation. Free Radic Biol Med 43(6):883–89810.1016/j.freeradbiomed.2007.06.014 ↗
47. David B, Pizúrová N et al (2004) Preparation of iron/graphite core–shell structured nanoparticles. J Alloys Compd 378(1):112–11610.1016/j.jallcom.2003.10.088 ↗
48. De Montferrand C, Hu L et al (2013) Iron oxide nanoparticles with sizes, shapes and compositions resulting in different magnetization signatures as potential labels for multiparametric detection. Acta Biomater 9(4):6150–615710.1016/j.actbio.2012.11.025 ↗
49. Di Carlo L, Conte DE et al (2014) Microwave-assisted fluorolytic sol–gel route to iron fluoride nanoparticles for Li-Ion batteries. Chem Commun 50(4):460–46210.1039/C3CC47413E ↗
50. Díaz B, Sánchez-Espinel C et al (2008) Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 4(11):2025–203410.1002/smll.200800199 ↗
51. DiMarino AM, Caplan AI et al (2013) Mesenchymal stem cells in tissue repair. Front Immunol 4:20110.3389/fimmu.2013.00201 ↗
52. Ding Y, Hu Y et al (2004) Polymer–monomer pairs as a reaction system for the synthesis of magnetic Fe3O4–polymer hybrid hollow nanospheres. Angew Chem Int Ed 43(46):6369–637210.1002/anie.200460408 ↗
53. Doan BT, Seguin J et al (2012) Functionalized single-walled carbon nanotubes containing traces of iron as new negative MRI contrast agents for in vivo imaging. Contrast Media Mol Imaging 7(2):153–15910.1002/cmmi.474 ↗
54. Dobrovolskaia MA, Patri AK et al (2009) Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed: Nanotechnol, Biol Med 5(2):106–11710.1016/j.nano.2008.08.001 ↗
55. Dong Y, Wang H et al (2017) Electrical and hydrogen reduction enhances kinetics in doped zirconia and ceria: I. grain growth study. J Am Ceram Soc 100(3):876–88610.1111/jace.14615 ↗
56. Duan H, Kuang M et al (2008) Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: new insights into spin disorder and proton relaxivity. J Phys Chem C 112(22):8127–813110.1021/jp8029083 ↗
57. Dürr S, Janko C et al (2013) Magnetic nanoparticles for cancer therapy. Nanotechnol Rev 2(4):395–40910.1515/ntrev-2013-0011 ↗
58. Duzgunes N, Düzgüneş N (2012) Nanomedicine: Infectious Diseases. Immunotherapy, Diagnostics, Antifibrotics, Toxicology and Gene Medicine, Elsevier
59. Eghbali P, Fattahi H et al (2016) Fluorophore-tagged superparamagnetic iron oxide nanoparticles as bimodal contrast agents for MR/optical imaging. J Iran Chem Soc 13(1):87–9310.1007/s13738-015-0715-8 ↗
60. Fang C, Zhang M (2009) Multifunctional magnetic nanoparticles for medical imaging applications. J Mater Chem 19(35):6258–626610.1039/b902182e ↗
61. Ferguson RM, Khandhar AP et al (2015) Magnetic particle imaging with tailored iron oxide nanoparticle tracers. IEEE Trans Med Imaging 34(5):1077–108410.1109/TMI.2014.2375065 ↗
62. Fornara A, Johansson P et al (2008) Tailored magnetic nanoparticles for direct and sensitive detection of biomolecules in biological samples. Nano Lett 8(10):3423–342810.1021/nl8022498 ↗
63. Freire T, Dutra L et al (2016) Fast ultrasound assisted synthesis of CHITOSAN-based magnetite NANOCOMPOSITES as a modified electrode sensor. In: Carbohydrate Polymers
64. Frey NA, Peng S et al (2009) Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem Soc Rev 38(9):2532–254210.1039/b815548h ↗
65. Gautam A, van Veggel FC (2013) Synthesis of nanoparticles, their biocompatibility, and toxicity behavior for biomedical applications. J Mater Chem B 1(39):5186–520010.1039/c3tb20738b ↗
66. Gessner A, Lieske A et al (2002) Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm 54(2):165–17010.1016/S0939-6411(02)00081-4 ↗
67. Gessner A, Lieske A et al (2003) Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res A 65(3):319–32610.1002/jbm.a.10371 ↗
68. Glasgow W, Fellows B et al (2016) Continuous synthesis of iron oxide (Fe 3 O 4) nanoparticles via thermal decomposition. Particuology 26:47–5310.1016/j.partic.2015.09.011 ↗
69. Gogola D, Štrbák O et al (2013) Contrast agents based on magnetic nanoparticles and its interaction with surrounding environment during contrast imaging. MEASUREMENT:299–302
70. Grabinski CM, Salaklang J et al (2014) Multifunctionalized spions for nuclear targeting: cell uptake and gene expression. Nano 9(01):145000910.1142/S179329201450009X ↗
71. Gref R, Lück M et al (2000) ‘Stealth’corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18(3):301–31310.1016/S0927-7765(99)00156-3 ↗
72. Guardia P, Batlle-Brugal B et al (2007) Surfactant effects in magnetite nanoparticles of controlled size. J Magn Magn Mater 316(2):e756–e75910.1016/j.jmmm.2007.03.085 ↗
73. Gupta AK, Curtis AS (2004) Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci Mater Med 15(4):493–49610.1023/B:JMSM.0000021126.32934.20 ↗
74. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–402110.1016/j.biomaterials.2004.10.012 ↗
75. Gupta AK, Wells S (2004) Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience 3(1):66–7310.1109/TNB.2003.820277 ↗
76. Gutiérrez L, Costo R et al (2015) Synthesis methods to prepare single-and multi-core iron oxide nanoparticles for biomedical applications. Dalton Trans 44(7):2943–295210.1039/C4DT03013C ↗
77. Hachani R, Lowdell M et al (2016a) Correction: polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. Nanoscale 8(7):439510.1039/C5NR90206A ↗
78. Hachani R, Lowdell M et al (2016b) Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. Nanoscale 8(6):3278–328710.1039/C5NR03867G ↗
79. Hadjipanayis CG, Bonder MJ et al (2008) Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia. Small 4(11):1925–192910.1002/smll.200800261 ↗
80. Hajba L, Guttman A (2016) The use of magnetic nanoparticles in cancer theranostics: toward handheld diagnostic devices. Biotechnol Adv 34(4):354–36110.1016/j.biotechadv.2016.02.001 ↗
81. Halliwell B, Gutteridge JM (2015) Free radicals in biology and medicine. Oxford University Press, USA10.1093/acprof:oso/9780198717478.001.0001 ↗
82. Hao R, Xing R et al (2010) Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv Mater 22(25):2729–274210.1002/adma.201000260 ↗
83. Harisinghani MG, Barentsz J et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25):2491–249910.1056/NEJMoa022749 ↗
84. Haynes CL, Hurley KR et al (2016) Mesoporous silica-coated nanoparticles. US Patent 20,160 051:471
85. Hoshino A, Fujioka K et al (2004) Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 4(11):2163–216910.1021/nl048715d ↗
86. Huang H, Zhang X-F et al (2013) Manipulated electromagnetic losses by integrating chemically heterogeneous components in Fe-based core/shell architecture. J Appl Phys 113(8):08431210.1063/1.4792669 ↗
87. Huang J, Zhong X et al (2012) Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles. Theranostics 2(1):8610.7150/thno.4006 ↗
88. Hufschmid R, Arami H et al (2015) Synthesis of phase-pure and monodisperse iron oxide nanoparticles by thermal decomposition. Nanoscale 7(25):11142–1115410.1039/C5NR01651G ↗
89. Huh Y-M, Jun Y-w et al (2005) In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 127(35):12387–1239110.1021/ja052337c ↗
90. Hurley KR, Ring HL et al (2016) Predictable heating and positive MRI contrast from a mesoporous silica-coated iron oxide nanoparticle. In: Molecular pharmaceutics
91. Hyeon T, Lee SS et al (2001) Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc 123(51):12798–1280110.1021/ja016812s ↗
92. Iqbal MZ, Ma X et al (2015) Silica-coated super-paramagnetic iron oxide nanoparticles (SPIONPs): a new type contrast agent of T 1 magnetic resonance imaging (MRI). J Mater Chem B 3(26):5172–518110.1039/C5TB00300H ↗
93. Jae-Hyun L, Yong-Min H et al (2007) Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13(1):9510.1038/nm1467 ↗
94. Jagadale TC, Takale SP et al (2008) N-doped TiO2 nanoparticle based visible light photocatalyst by modified peroxide sol–gel method. J Phys Chem C 112(37):14595–1460210.1021/jp803567f ↗
95. Jain S, Rathi VV et al (2012) Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine 7(9):1311–133710.2217/nnm.12.31 ↗
96. Jana NR, Chen Y et al (2004) Size-and shape-controlled magnetic (Cr, Mn, Fe, Co, Ni) oxide nanocrystals via a simple and general approach. Chem Mater 16(20):3931–393510.1021/cm049221k ↗
97. Jang J t, Nah H et al (2009) Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew Chem 121(7):1260–126410.1002/ange.200805149 ↗
98. Jennings LE, Long NJ (2009) ‘Two is better than one’—probes for dual-modality molecular imaging. Chem Commun (24):3511–352410.1039/b821903f ↗
99. Jing, X.-h., L. Yang, et al. (2008). In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine 75(4): 432-438.10.1016/j.jbspin.2007.09.013 ↗
100. Jitianu A, Raileanu M et al (2006) Fe3O4–SiO2 nanocomposites obtained via alkoxide and colloidal route. J Sol-Gel Sci Technol 40(2-3):317–32310.1007/s10971-006-9321-7 ↗